Article thumbnail

Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries

By Hitoshi Oshitani, Taro Kamigaki and Akira Suzuki


Summary line: A pandemic is a global issue, and pandemic preparedness should be considered from a global perspective

Topics: Perspective
Publisher: Centers for Disease Control and Prevention
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). A systematic analytic approach to pandemic infl uenza preparedness planning. PLoS Med.
  2. Antiviral resistance in infl uenza viruses—implications for management and pandemic response.
  3. (2005). Assembly. Revision of the international health regulations: WHA 58.3.2005.
  4. (2005). Assembly. Strengthening pandemic-infl uenza preparedness and response:WHA58.5.
  5. Children’s Fund. UNICEF progress report. Avian infl uenza and human infl uenza pandemic preparedness.
  6. Commentary: from scarcity to abundance: pandemic vaccines and other agents for “have not” countries. J Public Health Policy. 2007;28:322–40. Address for correspondence: Hitoshi Oshitani,
  7. Containing pandemic infl uenza at the source.
  8. (2007). Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic infl uenza mitigation in the United States.
  9. (2006). Distribution of amantadine-resistant H5N1 avian infl uenza variants in Asia. J Infect Dis.
  10. Effect of handwashing on child health: a randomised controlled trial.
  11. Estimation of potential global pandemic infl uenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis.
  12. (2001). Excess mortality due to pneumonia or infl uenza seasons among persons with acquired immunodefi ciency syndrome. Arch Intern Med.
  13. (2006). FluSurge—a tool to estimate demand for hospital services during the next pandemic infl uenza. Med Decis Making.
  14. (2006). Hospital preparedness for pandemic infl uenza. Biosecur Bioterror.
  15. How prepared is Europe for pandemic infl uenza? Analysis of national plans.
  16. (2006). Interactions between infl uenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis.
  17. Mitigation strategies for pandemic infl uenza in the United States.
  18. (2005). Modeling the impact of pandemic infl uenza on Pacifi c Islands. Emerg Infect Dis.
  19. Nonpharmaceutical interventions implemented by US cities during the 1918–1919 infl uenza pandemic.
  20. (2007). Optimizing the dose of pre-pandemic infl uenza vaccines to reduce the infection attack rate. PLoS Med.
  21. (2006). Organization. Global pandemic infl uenza action plan to increase vaccine supply. WHO/IVB/06.13
  22. (2005). Organization. WHO checklist for infl uenza pandemic preparedness planning: WHO/CDS/CSR/GIP/2005.4.
  23. (2004). Organization. WHO guidelines on the use of vaccines and antivirals during infl uenza pandemics: WHO/CDS/CSR/ RMD/2004.8.
  24. Oseltamivir becomes plentiful—but still not cheap.
  25. (2003). Pandemic infl uenza and the global vaccine supply. Clin Infect Dis.
  26. Pandemic infl uenza preparedness in the Asia-Pacifi c region.
  27. Pandemic infl uenza-implications for critical care resources in Australia and New Zealand.
  28. Perspectives on antiviral use during pandemic infl uenza.
  29. Potential benefi ts and limitations of various strategies to mitigate the impact of an infl uenza pandemic.
  30. (2006). Priority setting for pandemic infl uenza: an analysis of national preparedness plans. PLoS Med.
  31. Safety and immunogenicity of an inactivated adjuvanted whole-virion infl uenza A (H5N1) vaccine: a phase I randomised controlled trial.
  32. Safety and immunogenicity of an inactivated subvirion infl uenza A (H5N1) vaccine.
  33. Strategies for containing an emerging infl uenza pandemic in Southeast Asia.
  34. Strategies for mitigating an infl uenza pandemic.
  35. (1999). The economic impact of pandemic infl uenza in the United States: priorities for intervention. Emerg Infect Dis.
  36. (1991). The geography and mortality of the 1918 infl uenza pandemic. Bull Hist Med.
  37. (2002). Updating the accounts: global mortality of the 1918–1920 “Spanish” infl uenza pandemic. Bull Hist Med.
  38. (2006). Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis.
  39. (2006). World Health Organization Writing Group. Non-pharmaceutical interventions for pandemic infl uenza, national and community measures. Emerg Infect Dis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.